The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary
manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its …

The potential of commensal bacteria to modulate host immunity remains largely uncharacterized,
largely due to the vast number of strains that comprise the human gut microbiota. We …

Gastrointestinal symptoms are common in COVID-19 patients but the nature of the gut
immune response to SARS-CoV-2 remains poorly characterized, partly due to the difficulty of …

The building evidence for the contribution of microbiota to human disease has spurred an
effort to develop therapies that target the gut microbiota. This is particularly evident in …

Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of
coronavirus disease 2019 (COVID-19), we investigated intestinal infection with severe acute …

Background and aims Immune dysregulation caused by SARS-CoV-2 infection is thought to
play a pathogenic role in COVID-19. SARS-CoV-2 can infect a variety of host cells, including …

Despite being the most abundantly secreted immunoglobulin isotype, the pattern of
reactivity of immunoglobulin A (IgA) antibodies toward each individual’s own gut commensal …

Autoreactive T cells specific for islet autoantigens develop in type 1 diabetes (T1D) by
escaping central as well as peripheral tolerance. The current paradigm for development of islet …

How bacterial strains within a complex human microbiota collectively shape intestinal T cell
homeostasis is not well understood. Methods that quickly identify effector strains or species …